Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2020-06-15
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L01XX68
|
| gptkbp:brand |
gptkb:Zepzelca
|
| gptkbp:CASNumber |
497871-47-3
|
| gptkbp:chemicalFormula |
C41H44N4O10S
|
| gptkbp:genericName |
lurbinectedin
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zepzelca
|
| gptkbp:indication |
Small Cell Lung Cancer
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Jazz_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
antineoplastic agent
DNA minor groove binder |
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
gptkb:anemia
nausea fatigue neutropenia increased liver enzymes |
| gptkbp:bfsParent |
gptkb:PharmaMar
gptkb:Jazz_Pharmaceuticals |
| gptkbp:bfsLayer |
7
|